UBS Group »

Alaunos Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Alaunos Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 295k10k15k2000400060008000
Value ($)Share countHistorical TCRT position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $15k 7.9k 1.91
2024-09-30 $3.3k 1.0k 3.22

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Alaunos Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
Citigroup
Tower Research Capital
Morgan Stanley
Advisor Group Holdings
Bnp Paribas Arbitrage, Snc
Group One Trading
Atlantic Trust
Wells Fargo & Company
Sugarloaf Wealth Management
Bank of America Corporation
Royal Bank of Canada

View all funds holding Alaunos Therapeutics